Sarepta Therapeutics, Inc. share price logo

Sarepta Therapeutics, Inc. Share Price

NASDAQ: SRPT

Large Cap

$21.27

+0.93

(+4.57%)

Live

as on

Sarepta Therapeutics, Inc. Stock Performance

as on December 20, 2025 at 12:37 am IST

  • Day's Low

    Day's High

    $20.33
    $21.48
    downward going graph

    4.42%

    Downside

    0.99%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $10.42
    $129.84
    downward going graph

    51.03%

    Downside

    510.44%

    Upside

    downward going graph

Sarepta Therapeutics, Inc. share price movements today

Previous Close
$20.34
Open
$20.33
Volume
1.4M
Day's Low - High
$20.33 - $21.48
52 Week Low - High
$10.42 - $129.84

Sarepta Therapeutics, Inc. Historical Returns

1 Month Return
+ 24.1 %
3 Month Return
+ 16.7 %
1 Year Return
-82.97 %
3 Year Return
-83.46 %
5 Year Return
-88.4 %

Sarepta Therapeutics, Inc. Stock Fundamentals & Key Indicators

Check Sarepta Therapeutics, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.1B

EPS (TTM)

-2.013

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

26.64%

PE Ratio (TTM)

276.74

Industry PE ratio

17.123164556962024

PEG Ratio

159.25

EBITDA

-36.3M

Revenue (TTM)

2.4B

Profit Margin

-11.25%

Return On Equity TTM

-21.37%

Sarepta Therapeutics, Inc. Stock Valuation

Track how Sarepta Therapeutics, Inc. P/E has moved over time to understand its valuation trends.

Sarepta Therapeutics, Inc. in the last 5 years

  • Overview

  • Trends

Lowest (-94.84x)

March 31, 2025

Industry (17.12x)

December 19, 2025

Today (276.74x)

December 19, 2025

Highest (110.59x)

September 30, 2024

LowHigh

Today’s Price to Earnings Ratio: 276.74x

Sarepta Therapeutics, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Sarepta Therapeutics, Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Sarepta Therapeutics, Inc. image
Sarepta Therapeutics, Inc.
BUY$2.1B-88.4%276.74-11.25%
Insmed Incorporated image
Insmed Incorporated
BUY$35.5B348.68%-16.34-264.83%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$52.3B178.14%1237.621.36%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$114.7B88.99%31.4431.35%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$79.4B50.08%17.9532.13%

Stock Returns calculator for Sarepta Therapeutics, Inc. Stock including INR - Dollar returns

The Sarepta Therapeutics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Sarepta Therapeutics, Inc. investment value today

Current value as on today

₹23,104

Returns

₹76,896

(-76.9%)

Returns from Sarepta Therapeutics, Inc. Stock

₹82,196 (-82.2%)

Dollar Returns*

₹5,300 (+5.3%)

Analyst Recommendation on Sarepta Therapeutics, Inc. Stock

Based on 29 analysts

BUY

82.76%

Buy

17.24%

Hold

0.00%

Sell

Based on 29 analysts, 82.76% of analysts recommend a 'BUY' rating for Sarepta Therapeutics, Inc.. Average target price of $20.61

Sarepta Therapeutics, Inc. Share Price Target

Get share price movements and forecasts by analysts on Sarepta Therapeutics, Inc..

What analysts predicted

-3.2%DOWNSIDE

Target Price

$20.61

Current Price

$21.27

Analyzed by

29 Analysts

Target

$20.61

Sarepta Therapeutics, Inc. target price $20.61, a slight downside of -3.2% compared to current price of $21.27. According to 29 analysts rating.

Sarepta Therapeutics, Inc. Stock’s Investor Sentiment and Interest

Investment in Sarepta Therapeutics, Inc. Shares on INDmoney has dropped by -70.11% over the past 30 days, indicating reduced transactional activity.

Time period: to

Change:-70.11% versus previous 30 day period

Search interest for Sarepta Therapeutics, Inc. Stock has decreased by -9% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-9% versus previous 30 day period

Sarepta Therapeutics, Inc. Quarterly Profit & Loss

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Total Revenue
261
331
396
413
362
467
658
744
611
399
Gross Profit
227
294
352
362
318
375
526
607
458
236
Operating Income
-133
-20
24
34
0
22
161
-300
115
-62
EBITDA
1
-17
60
54
27
48
186
-369
169
-181
Interest Expense
5
5
5
4
4
4
4
4
5
9
Depreciation
10
10
11
8
8
9
10
9
10
18
Income Before Tax
-14
-33
40
41
13
34
171
-383
153
-194
Income Tax Expense
9
7
-5
5
7
0
12
63
-43
-14
Net Income
-23
-40
45
36
6
33
159
-447
196
-179
Net Profit Margin
-9.16%
-12.34%
11.51%
8.74%
1.78%
7.19%
24.16%
-60.08%
32.22%
-45.06%

Sarepta Therapeutics, Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
1
5
154
301
380
540
701
933
1,243
1,901
Gross Profit
1
5
147
266
324
476
604
793
1,092
1,582
Operating Income
-220
-266
-171
-343
-705
-564
-459
-536
-267
218
EBITDA
-214
-261
-34
-316
-658
-453
-317
-582
-439
333
Interest Expense
1
0
5
33
30
59
63
53
22
18
Depreciation
-
-
8
12
30
26
38
41
43
37
Income Before Tax
-220
-267
-48
-362
-713
-553
-418
-689
-520
260
Income Tax Expense
-5
-7
2
0
1
1
0
13
15
25
Net Income
-220
-267
-50
-361
-715
-554
-418
-703
-535
235
Net Profit Margin
-17560.26%
-4930.18%
-32.79%
-120.22%
-187.77%
-102.60%
-59.66%
-75.40%
-43.11%
12.37%

Sarepta Therapeutics, Inc. Quarterly Cash Flow

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Net Income
-40
45
36
6
33
159
-447
196
-179
Operating Cash Flow
-114
-54
-242
14
-70
92
-583
261
-14
Investing Cash Flow
-210
-64
218
-98
-128
764
-291
32
-
Financing Cash Flow
15
1
22
39
13
48
12
-23
-117
Change in Cash
-309
-117
-1
-43
-185
905
-862
269
102

Sarepta Therapeutics, Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-267
-50
-361
-715
-554
-418
-703
-535
235
Operating Cash Flow
-245
-231
-388
-456
107
-443
-325
-500
-205
Investing Cash Flow
-90
-178
-370
286
-121
495
-1,046
-165
755
Financing Cash Flow
378
888
530
642
682
561
232
125
124
Change in Cash
42
477
-228
472
668
613
-1,139
-541
674

Global Institutional Holdings in Sarepta Therapeutics, Inc.

Funds
Holdings
BlackRock Inc
11.57%
Vanguard Group Inc
8.75%
State Street Corp
4.49%
D. E. Shaw & Co LP
4.28%
Wellington Management Company LLP
2.42%
See all

Sarepta Therapeutics, Inc. News & Key Events

    Insights on Sarepta Therapeutics, Inc.

    Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

    • imgPOSITIVE IMPACT

      Price Rise

      img

      In the last 1 month, SRPT stock has moved up by 24.1%

    • imgNO EFFECT

      Against Peers

      img

      In the last 1 year, Insmed Incorporated has given 140.0% return, outperforming this stock by 223.0%

    • imgNO EFFECT

      Against Peers

      img

      In the last 3 years, Insmed Incorporated has given 809.6% return, outperforming this stock by 893.1%

    • imgNEGATIVE IMPACT

      Revenue Fall

      img

      Revenue is down for the last 3 quarters, 744.85M → 399.35M (in $), with an average decrease of 26.3% per quarter

    • imgNEGATIVE IMPACT

      Profit Down

      img

      Netprofit is down for the last 2 quarters, 196.89M → -179.94M (in $), with an average decrease of 191.4% per quarter

    About Sarepta Therapeutics, Inc.

    sarepta therapeutics is a biopharmaceutical company focused on the discovery and development of unique rna-targeted therapeutics for the treatment of rare, infectious and other diseases. the company is primarily focused on rapidly advancing the development of its potentially disease-modifying dmd drug candidates, including its lead dmd product candidate, eteplirsen, designed to skip exon 51. sarepta is also developing therapeutics for the treatment of infectious diseases, such as drug-resistant bacteria and other rare human diseases. for more information, please visit us at www.sarepta.com.
    OrganisationSarepta Therapeutics, Inc.
    Headquarters215 First Street, Cambridge, MA, United States, 02142
    IndustryHealth Technology
    CEOMr. Douglas S. Ingram Esq., J.D.
    E-voting on sharesClick here to vote

    Key Management of Sarepta Therapeutics, Inc.

    Name

    Title

    Mr. Douglas S. Ingram Esq., J.D.

    CEO & Director

    Mr. Ian Michael Estepan

    President & COO

    Ryan H. Wong

    Executive VP & CFO

    Rachael Potter Ph.D.

    Chief Scientific Officer

    Ms. Cristin L. Rothfuss J.D.

    Executive VP, Chief General Counsel & Corporate Secretary

    Patrick Moss Pharm.D.

    Executive VP & Chief Commercial Officer

    Dr. Louise R. Rodino-Klapac Ph.D.

    President of Research & Development and Technical Operations

    Tamara Thornton

    Director of Finance, Treasury & Investor Relations

    Ms. Alison Nasisi

    Executive VP & Chief People Officer

    Dr. Diane L. Berry Ph.D.

    Executive VP and Chief of Global Policy & Advocacy Officer

    FAQs

    What is Sarepta Therapeutics, Inc. share price today?

    Sarepta Therapeutics, Inc. share price today is $21.27 as on . Sarepta Therapeutics, Inc. share today touched a day high of $21.48 and a low of $20.33.

    What is the 52 week high and 52 week low for Sarepta Therapeutics, Inc. share?

    Sarepta Therapeutics, Inc. share touched a 52 week high of $129.84 on and a 52 week low of $10.42 on . Sarepta Therapeutics, Inc. stock price today i.e. is trending at $21.27,which is 83.62% down from its 52 week high and 104.22% up from its 52 week low.

    What is Sarepta Therapeutics, Inc.'s market capitalisation today?

    Sarepta Therapeutics, Inc. market capitalisation is $0.00T as on .

    How to invest in Sarepta Therapeutics, Inc. Stock (SRPT) from India?

    1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
    2. Step 2: Search for Sarepta Therapeutics, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Sarepta Therapeutics, Inc. Shares that will get you 0.0705 shares as per Sarepta Therapeutics, Inc. share price of $21.27 per share as on December 20, 2025 at 12:37 am IST.

    What is the minimum amount required to buy Sarepta Therapeutics, Inc. Stock (SRPT) from India?

    Indian investors can start investing in Sarepta Therapeutics, Inc. (SRPT) shares with as little as ₹89.627 or $1 (as of ) using the INDmoney app.
    For example: If you want to invest $10 or ₹896.27 in Sarepta Therapeutics, Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Sarepta Therapeutics, Inc. share’s latest price of $21.27 as on December 20, 2025 at 12:37 am IST, you will get 0.4701 shares of Sarepta Therapeutics, Inc.. Learn more about fractional shares .

    What are the returns that Sarepta Therapeutics, Inc. has given to Indian investors in the last 5 years?

    Sarepta Therapeutics, Inc. stock has given -88.4% share price returns and 22.86% dollar appreciation to an Indian investor in the last 5 years.
    Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?